This e-learning course discusses managing non-metastatic castration-resistant prostate cancer (nmCRPC) and the implications of new imaging modalities. The course considers the application of conventional imaging vs. new imaging modalities and the potential impact of next-generation imaging on treatment options.
Two alternative approaches are presented:

  • Delay time to systemic therapy
  • Use systemic medications sooner
This course has been accredited by EACCME® for 1 ECMEC® (as detailed within the Introduction and Objectives below).